These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4425137)

  • 1. Stimulus properties of mescaline and N-methylated derivatives: difference in peripheral and direct central administration.
    Browne RG; Harris RT; Ho BT
    Psychopharmacologia; 1974; 39(1):43-56. PubMed ID: 4425137
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences in tolerance to mescaline produced by peripheral and direct central administration.
    Tilson HA; Sparber SB
    Psychopharmacologia; 1971; 19(4):313-23. PubMed ID: 5109405
    [No Abstract]   [Full Text] [Related]  

  • 3. Excitatory and inhibitory effects of mescaline on shuttle avoidance in the rat.
    Bridger WH; Mandel IJ
    Biol Psychiatry; 1971; 3(4):379-85. PubMed ID: 5163821
    [No Abstract]   [Full Text] [Related]  

  • 4. Tolerance and cross-tolerance to mescaline and amphetamine as a function of central and peripheral administration.
    Sparber SB; Tilson HA
    Psychopharmacologia; 1972; 23(3):220-30. PubMed ID: 5067530
    [No Abstract]   [Full Text] [Related]  

  • 5. Mescaline and lysergic acid diethylamide (LSD) as discriminative stimuli.
    Hirschhorn ID; Winter JC
    Psychopharmacologia; 1971; 22(1):64-71. PubMed ID: 5119576
    [No Abstract]   [Full Text] [Related]  

  • 6. Discriminative stimulus properties of mescaline: mescaline or metabolite?
    Browne RG; Ho BT
    Pharmacol Biochem Behav; 1975; 3(1):109-14. PubMed ID: 1129346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of chronic mescaline administration on operant behavior in the pigeon.
    Hadorn D; Mandell AJ; Segal DS
    Behav Biol; 1976 Jul; 17(3):403-9. PubMed ID: 971192
    [No Abstract]   [Full Text] [Related]  

  • 8. An analysis of some discriminative properties of d-amphetamine.
    Kuhn DM; Appel JB; Greenberg I
    Psychopharmacologia; 1974; 39(1):57-66. PubMed ID: 4138622
    [No Abstract]   [Full Text] [Related]  

  • 9. Mescaline: no tolerance to excitatory effects.
    Bridger WH; Mandel IJ; Stoff DM
    Biol Psychiatry; 1973 Oct; 7(2):129-38. PubMed ID: 4748845
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of mescaline and its derivative N-[3,4,5-trimethoxyphenylethyl]-aziridine on the spatial orientation of rats in a T-maze.
    Koupilová M; Herink J
    Physiol Bohemoslov; 1989; 38(6):497-502. PubMed ID: 2534189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hallucinogens as discriminative stimuli.
    Winter JC
    Fed Proc; 1974 Jul; 33(7):1825-32. PubMed ID: 4209212
    [No Abstract]   [Full Text] [Related]  

  • 12. Mescaline and homoveratrylamine as discriminative stimuli in rats.
    Bueno OF
    Acta Physiol Lat Am; 1975; 25(1):77-9. PubMed ID: 1221818
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of serotonin in the discriminative stimulus properties of mescaline.
    Browne RG; Ho BT
    Pharmacol Biochem Behav; 1975; 3(3):429-35. PubMed ID: 125425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EEG and behavioral effects in animals of some amphetamine derivatives with hallucinogenic properties.
    Florio V; Fuentes JA; Ziegler H; Longo VG
    Behav Biol; 1972 Jun; 7(3):401-14. PubMed ID: 5067663
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animals.
    Hardman HF; Haavik CO; Seevers MH
    Toxicol Appl Pharmacol; 1973 Jun; 25(2):299-309. PubMed ID: 4197635
    [No Abstract]   [Full Text] [Related]  

  • 16. Configurations of the interoceptive discriminative stimulus effects of ethanol and nicotine with two different exteroceptive contexts in rats: Extinction & recovery.
    Troisi JR; Craig EM
    Behav Processes; 2015 Jun; 115():169-80. PubMed ID: 25895858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance and cross-tolerance among psychotomimetic drugs.
    Appel JB; Freedman DX
    Psychopharmacologia; 1968 Sep; 13(3):267-74. PubMed ID: 5679628
    [No Abstract]   [Full Text] [Related]  

  • 18. Action of a chronic administration of mescaline in dynamic behavioural situations.
    Fundaro' A; Molinengo L; Cassone MC; Orsetti M
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(1):41-8. PubMed ID: 3704173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of acute and chronic administration of chlorpromazine on the acquisition and extinction of positively reinforced operant responses.
    Ortiz A; Glover A; Lang WJ
    Physiol Behav; 1971 Apr; 6(4):407-12. PubMed ID: 5148752
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction of "stress" and the response to mescaline.
    Smythies JR; Bradley RJ; Johnston VS
    Nature; 1967 Sep; 215(5106):1179-80. PubMed ID: 6070342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.